ARENA PHARMACEUTICALS INC Income Statement

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Operations and Comprehensive (Loss) Income

In millions of USD; shares in millions, except per-share amounts

	FY2021 12 months to Dec 31, 2021	FY2020 12 months to Dec 31, 2020	FY2019 12 months to Dec 31, 2019	FY2018 12 months to Dec 31, 2018	FY2017 12 months to Dec 31, 2017
Revenues
Collaboration and other revenue
United Therapeutics revenue
Royalty revenue
Total revenues
Operating costs and expenses
Research and development
Acquired in-process research and development
Selling, general and administrative
Transaction costs
United Therapeutics
Total transaction costs
Litigation settlement expense, net
Total operating costs and expenses

(Loss) income from operations
Interest and other income (expense)
Interest income
Interest expense
Other (expense) income, net
Gain on deconsolidation of Longboard
Gain from Longboard equity method investment
Total interest and other income, net

(Loss) income before income taxes
Income tax provision
Income (loss) from continuing operations
Net income (loss)
Less net loss attributable to noncontrolling interest in consolidated variable interest entity
(Loss) income from continuing operations
Loss from discontinued operations
Net (loss) income
Continuing operations
Discontinued operations
Net income (loss) attributable to stockholders of Arena per share, basic and diluted
Shares used in calculating net income (loss) attributable to stockholders of Arena per share, basic and diluted
Foreign currency translation adjustment
Unrealized loss on available-for-sale investments
Comprehensive income (loss)
Less comprehensive loss attributable to noncontrolling interest in consolidated variable interest entity
Unrealized (loss) gain on available-for-sale investments
Comprehensive (loss) income
Net (loss) income per share, basic:
Continuing operations
Discontinued operations
Net (loss) per share, basic (dollars per share)
Net (loss) per share, diluted (dollars per share)

Net (loss) income per share, diluted:
Continuing operations
Discontinued operations
Shares used in calculating net (loss) income per share, basic (in shares)
Shares used in calculating net (loss) income per share, diluted (in shares)

Comments